ClinicalTrials.gg
Drug

Isosorbide clinical trials

studies test it
4
open now
2
in phase 3
1
first study started
2007

How each study uses Isosorbide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Isosorbide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Jan 1974 · ISMOTIC · NDA 017063 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

Isobide
1

Studies by the year they started

4 studies that test it; most in 2007 (1)

Studies that test Isosorbide, by start year
YearStudies
20071
20131
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 1

Alvogen Korea (1) · Vanderbilt University (1) · Lunan Better Pharmaceutical Co., LTD. (1) · AbClon (1)

Often tested with

Tested in the same studies.

Omega-N-Methylarginine (1) · Bradykinin (1) · Sildenafil (1) · Anti-CD19 CAR T Cells AT101 (1) · Gossypol-acetic acid (1) · Gossypol acetic acid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Isosorbide, phase 3 first.

Studies

Open first, then newest update. How each study uses Isosorbide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Codes

What other systems call Isosorbide · ClinicalTrials.gg INT007697

  • MeSH (NLM) D007547IsosorbideConfirmed NLM, Wikidata
  • UNII (FDA) WXR179L51SISOSORBIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 6057Confirmed FDA, Wikidata
  • Wikidata Q1243800isosorbideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C60773IsosorbideOne source FDA
  • DrugBank DB09401One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.